AstraZeneca PLC (AZN)
77.20
-0.41
(-0.53%)
USD |
NASDAQ |
May 10, 16:00
77.20
0.00 (0.00%)
After-Hours: 20:00
AstraZeneca Cash from Operations (TTM): 9.698B for March 31, 2024
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 9.698B |
December 31, 2023 | 10.34B |
September 30, 2023 | 10.36B |
June 30, 2023 | 10.18B |
March 31, 2023 | 9.709B |
December 31, 2022 | 9.808B |
September 30, 2022 | 8.828B |
June 30, 2022 | 7.617B |
March 31, 2022 | 7.261B |
December 31, 2021 | 5.963B |
September 30, 2021 | 6.343B |
June 30, 2021 | 6.446B |
March 31, 2021 | 6.594B |
December 31, 2020 | 4.799B |
September 30, 2020 | 4.376B |
June 30, 2020 | 3.657B |
March 31, 2020 | 3.495B |
December 31, 2019 | 2.969B |
September 30, 2019 | 3.818B |
June 30, 2019 | 3.184B |
March 31, 2019 | 2.371B |
December 31, 2018 | 2.618B |
September 30, 2018 | 1.391B |
June 30, 2018 | 3.165B |
March 31, 2018 | 3.35B |
Date | Value |
---|---|
December 31, 2017 | 3.578B |
September 30, 2017 | 4.541B |
June 30, 2017 | 3.109B |
March 31, 2017 | 3.04B |
December 31, 2016 | 4.145B |
September 30, 2016 | 2.756B |
June 30, 2016 | 3.69B |
March 31, 2016 | 4.589B |
December 31, 2015 | 3.324B |
September 30, 2015 | 4.595B |
June 30, 2015 | 4.80B |
March 31, 2015 | 5.799B |
December 31, 2014 | 7.058B |
September 30, 2014 | 7.694B |
June 30, 2014 | 6.862B |
March 31, 2014 | 6.389B |
December 31, 2013 | 7.40B |
September 30, 2013 | 7.77B |
June 30, 2013 | 7.961B |
March 31, 2013 | 7.606B |
December 31, 2012 | 6.948B |
September 30, 2012 | 7.169B |
June 30, 2012 | 7.783B |
March 31, 2012 | 7.471B |
December 31, 2011 | 7.821B |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
2.969B
Minimum
Dec 2019
10.36B
Maximum
Sep 2023
6.773B
Average
6.52B
Median
Cash from Operations (TTM) Benchmarks
GSK PLC | 9.572B |
Amgen Inc | 8.096B |
Sanofi SA | -- |
Viking Therapeutics Inc | -54.87M |
Fusion Pharmaceuticals Inc | -81.80M |